Losartan potassium and Brovana drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Losartan potassium (losartan potassium) and Brovana (arformoterol tartrate). Common drug interactions include dizziness among females and fall among males.

The phase IV clinical study analyzes what interactions people have when they take Losartan potassium and Brovana. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Losartan potassium?

Losartan potassium has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 51,511 Losartan potassium users. Check the latest studies of Losartan potassium.

What is Brovana?

Brovana has active ingredients of arformoterol tartrate. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 3,656 Brovana users. Check the latest studies of Brovana.

On Jul, 11, 2026

35 people who take Losartan potassium and Brovana together, and have interactions are studied.

Losartan potassium and Brovana drug interactions.

What are the common drug interactions of Losartan Potassium and Brovana, by gender? *:

female:

Dizziness
Drug intolerance (drug sensitivity)
Dry mouth
Dyspnoea exertional (breathlessness or shortness of breath)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Interstitial lung disease
Lymphadenopathy (disease or enlargement of lymph nodes)
Multiple allergies (allergy to multiple agents)
Oedema (fluid collection in tissue)
Oxygen saturation decreased

male:

Fall
Injury
Urinary tract infection
Accidental exposure
Adenoma benign (non-cancerous tumour -secreting)
Agitation (state of anxiety or nervous excitement)
Akinesia (loss of control of voluntary muscle movements)
Angina pectoris (chest pain due to ischemia of the heart muscle)
Anxiety
Arrhythmia (irregular heartbeat)

What are the common drug interactions of Losartan Potassium and Brovana, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Chronic kidney disease
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Renal failure (kidney dysfunction)
Renal impairment (severely reduced kidney function)
Renal tubular necrosis (death of kidney tubules)
Respiratory failure (inadequate gas exchange by the respiratory system)

60+:

Dyspnoea (difficult or laboured respiration)
Hypoxia (low oxygen in tissues)
Blood pressure diastolic decreased
Chest discomfort
Diarrhoea
Dizziness
Drug intolerance (drug sensitivity)
Dry mouth
Dyspnoea exertional (breathlessness or shortness of breath)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 8 people, 22.86%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 5 people, 14.29%
Oedema Peripheral (superficial swelling): 4 people, 11.43%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 8.57%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 3 people, 8.57%
High Blood Cholesterol: 3 people, 8.57%
Burkitt Lymphoma (cancer of the lymphatic system): 3 people, 8.57%
Asthma: 3 people, 8.57%
Parkinson's Disease: 2 people, 5.71%
Pain: 2 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Losartan potassium and Brovana?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously